Publication:
The effect of peripherally administered cdp-choline in an acute inflammatory pain model: The role of α7 nicotinic acetylcholine receptor

dc.contributor.authorParker, Renee
dc.contributor.authorEisenach, James C.
dc.contributor.authorVincler, Michelle
dc.contributor.buuauthorGürün, Mine Sibel
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFarmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
dc.contributor.researcheridAAG-8716-2019
dc.contributor.scopusid55664349700
dc.date.accessioned2021-11-17T12:57:45Z
dc.date.available2021-11-17T12:57:45Z
dc.date.issued2009-05
dc.description.abstractBACKGROUND: CDP-choline (citicholine; cytidine-5'-diphosphate choline) is an endogenously produced nucleotide which, when injected intracerebroventricularly, exerts an antinociceptive effect in acute pain models mediated by central cholinergic mechanisms and alpha 7 nicotinic acetylcholine receptors (alpha 7nAChR). Previous reports also suggest that the peripheral cholinergic system has an antiinflammatory role mediated by alpha 7nAChRs on macrophages. METHODS: We used male Sprague-Dawley rats to assess the antihypersensitivity and antiinflammatory effect of CDP-choline after intraplantar injection of carrageenan (100 mu L, 2%). Mechanical paw withdrawal thresholds and paw thickness were measured by Randall-Selitto testing and microcallipers, respectively. All drugs were administered intraplantarly in a volume 50 mu L. RESULTS: CDP-choline (1, 2.5, 5 mu mol; intraplantar) increased the mechanical paw withdrawal threshold and decreased paw edema in a dose- and time-dependent manner in the carrageenan-injected hindpaw. CDP-choline administration to the noninflamed contralateral hindpaw did not alter ipsdateral inflammation. Methyllycaconitine (100 nmol), a selective alpha 7nAChR antagonist, completely blocked the effects of CDP-choline when administered to the inflamed hindpaw. However, the administration of methyllycaconitine to the contralateral hindpaw did not block the effects of CDP-choline in the ipsilateral paw. The administration of CDP-choline (5 mu mol) 10 min after carrageenan administration to the ipsilateral hindpaw did not reduce swelling and edema but did significantly reduce hypersensitivity. Treatment with CDP-choline decreased tumor necrosis factor-a production in the rat paw tissue after carrageenan. CONCLUSIONS: The results of this study suggest that intraplantar CDP-choline has antihypersensitivity and antiinflammatory effects mediated via alpha 7nAChRs in the carrageenan-induced inflammatory pain model.
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA (NS048158)
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA (GM48085)
dc.description.sponsorshipFulbright Commission Turkey
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of General Medical Sciences (NIGMS) (R01GM048085)
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of General Medical Sciences (NIGMS) (R37GM048085)
dc.identifier.citationGürün, M. S. vd. (2009). "The effect of peripherally administered cdp-choline in an acute inflammatory pain model: The role of α7 nicotinic acetylcholine receptor". Anesthesia and Analgesia, 108(5), 1680-1687.
dc.identifier.endpage1687
dc.identifier.issn0003-2999
dc.identifier.issue5
dc.identifier.pubmed19372354
dc.identifier.scopus2-s2.0-65349139499
dc.identifier.startpage1680
dc.identifier.urihttps://doi.org/10.1213/ane.0b013e31819dcd08
dc.identifier.urihttps://journals.lww.com/anesthesia-analgesia/Fulltext/2009/05000/The_Effect_of_Peripherally_Administered.51.aspx
dc.identifier.urihttp://hdl.handle.net/11452/22696
dc.identifier.volume108
dc.identifier.wos000265422300051
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.collaborationYurt dışı
dc.relation.journalAnesthesia and Analgesia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAnalgesic activity
dc.subjectHyperalgesia
dc.subjectCiticoline
dc.subjectResponses
dc.subjectNeurons
dc.subjectRats
dc.subjectSkin
dc.subjectPaw
dc.subjectAnesthesiology
dc.subject.emtreeAlpha 7 nicotinic acetylcholine receptor
dc.subject.emtreeCarrageenan
dc.subject.emtreeCholinergic receptor
dc.subject.emtreeCiticoline
dc.subject.emtreeSodium chloride
dc.subject.emtreeUnclassified drug
dc.subject.emtreeAconitine
dc.subject.emtreeAlpha-bungarotoxin receptor
dc.subject.emtreeAnalgesic agent
dc.subject.emtreeAntiinflammatory agent
dc.subject.emtreeBungarotoxin receptor
dc.subject.emtreeCiticoline
dc.subject.emtreeDrug derivative
dc.subject.emtreeMethyllycaconitine
dc.subject.emtreeNicotinic agent
dc.subject.emtreeNicotinic receptor
dc.subject.emtreeNicotinic receptor blocking agent
dc.subject.emtreeTumor necrosis factor alpha
dc.subject.emtreeAnimal experiment
dc.subject.emtreeAnimal model
dc.subject.emtreeArticle
dc.subject.emtreeControlled study
dc.subject.emtreeDrug dose comparison
dc.subject.emtreeInflammation
dc.subject.emtreeMacrophage
dc.subject.emtreeMale
dc.subject.emtreeNonhuman
dc.subject.emtreePain
dc.subject.emtreePaw edema
dc.subject.emtreePriority journal
dc.subject.emtreeRat
dc.subject.emtreeAnimal
dc.subject.emtreeChemically induced disorder
dc.subject.emtreeDisease model
dc.subject.emtreeDose response
dc.subject.emtreeDrug effect
dc.subject.emtreeEdema
dc.subject.emtreeInflammation
dc.subject.emtreeInjection
dc.subject.emtreeMetabolism
dc.subject.emtreePain
dc.subject.emtreePain assessment
dc.subject.emtreePain threshold
dc.subject.emtreeSprague Dawley rat
dc.subject.emtreeTime
dc.subject.meshAconitine
dc.subject.meshAnalgesics
dc.subject.meshAnimals
dc.subject.meshAnti-inflammatory agents
dc.subject.meshCarrageenan
dc.subject.meshCytidine diphosphate choline
dc.subject.meshDisease models, animal
dc.subject.meshDose-response relationship, drug
dc.subject.meshEdema
dc.subject.meshInflammation
dc.subject.meshInjections
dc.subject.meshMale
dc.subject.meshNicotinic antagonists
dc.subject.meshPain
dc.subject.meshPain measurement
dc.subject.meshPain threshold
dc.subject.meshRats
dc.subject.meshRats, sprague-dawley
dc.subject.meshReceptors, nicotinic
dc.subject.meshTime factors
dc.subject.meshTumor necrosis factor-alpha
dc.subject.meshNicotinic agonists
dc.subject.scopusCiticoline; Neuroprotective Agents; Glycerylphosphorylcholine
dc.subject.wosAnesthesiology
dc.titleThe effect of peripherally administered cdp-choline in an acute inflammatory pain model: The role of α7 nicotinic acetylcholine receptor
dc.typeArticle
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: